More recently, we found an increase in cell viability and cisplatin resistance upon NSCLC cell treatment with nicotine and/or BDNF, effects opposite to those observed by treatment of cells with propranolol [37]. The gene discussed is BDNF; the disease is non-small cell lung carcinoma.